Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Silymarin treatment of viral hepatitis: a systematic review.

Mayer KE, Myers RP, Lee SS.

J Viral Hepat. 2005 Nov;12(6):559-67. Review.

PMID:
16255756
2.

The use of silymarin in the treatment of liver diseases.

Saller R, Meier R, Brignoli R.

Drugs. 2001;61(14):2035-63. Review.

PMID:
11735632
3.

Does Silybum marianum play a role in the treatment of chronic hepatitis C?

Torres M, Rodríguez-Serrano F, Rosario DJ, Rodríguez-Perez F, Toro DH.

P R Health Sci J. 2004 Jun;23(2 Suppl):69-74.

PMID:
16929590
4.

Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C.

Gordon A, Hobbs DA, Bowden DS, Bailey MJ, Mitchell J, Francis AJ, Roberts SK.

J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):275-80.

PMID:
16460486
5.

An updated systematic review with meta-analysis for the clinical evidence of silymarin.

Saller R, Brignoli R, Melzer J, Meier R.

Forsch Komplementmed. 2008 Feb;15(1):9-20. doi: 10.1159/000113648. Review.

PMID:
18334810
6.

Milk thistle and the treatment of hepatitis.

Giese LA.

Gastroenterol Nurs. 2001 Mar-Apr;24(2):95-7. Review.

PMID:
11847735
7.
8.

A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis.

El-Kamary SS, Shardell MD, Abdel-Hamid M, Ismail S, El-Ateek M, Metwally M, Mikhail N, Hashem M, Mousa A, Aboul-Fotouh A, El-Kassas M, Esmat G, Strickland GT.

Phytomedicine. 2009 May;16(5):391-400. doi: 10.1016/j.phymed.2009.02.002.

9.

Meta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B.

Wei F, Liu SK, Liu XY, Li ZJ, Li B, Zhou YL, Zhang HY, Li YW.

Eur J Clin Microbiol Infect Dis. 2013 May;32(5):657-69. doi: 10.1007/s10096-012-1789-1. Review.

PMID:
23247631
10.

Bicyclol: a novel drug for treating chronic viral hepatitis B and C.

Liu GT.

Med Chem. 2009 Jan;5(1):29-43. Review.

PMID:
19149648
11.

Milk thistle in liver diseases: past, present, future.

Abenavoli L, Capasso R, Milic N, Capasso F.

Phytother Res. 2010 Oct;24(10):1423-32. doi: 10.1002/ptr.3207. Review.

PMID:
20564545
12.

[Hepatoprotective properties of silymarin].

Matveev AV, Koniaeva EI, Kurchenko VP, Shchekatikhina AS.

Eksp Klin Gastroenterol. 2011;(2):130-5. Review. Russian.

PMID:
21560654
13.

Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C.

Reddy KR, Belle SH, Fried MW, Afdhal N, Navarro VJ, Hawke RL, Wahed AS, Doo E, Meyers CM; SyNCH Study Group..

Clin Trials. 2012 Feb;9(1):102-12. doi: 10.1177/1740774511427064.

14.

Oral silymarin for chronic hepatitis C - a retrospective analysis comparing three dose regimens.

Huber R, Futter I, Lüdtke R.

Eur J Med Res. 2005 Feb 28;10(2):68-70.

PMID:
15817425
15.

Chronic hepatitis B: a wider range of therapeutic options.

[No authors listed]

Prescrire Int. 2007 Aug;16(90):157-62.

PMID:
17724844
17.

Clinical use of interferon in hepatitis B and C.

Schalm SW.

Verh K Acad Geneeskd Belg. 2009;71(1-2):87-99. Review.

PMID:
19739400
18.
19.

[Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial (author's transl)].

Bode JC, Schmidt U, Dürr HK.

Med Klin. 1977 Mar 25;72(12):513-8. German.

PMID:
840125
20.

Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials.

Fabrizi F, Dixit V, Messa P, Martin P.

J Viral Hepat. 2008 Feb;15(2):79-88. doi: 10.1111/j.1365-2893.2007.00907.x.

PMID:
18184190

Supplemental Content

Support Center